Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for actavis
Never Too Late: if you missed The IPKat last week Never Too Late: if you missed The IPKat last week Reviewed by Magdaleen Jooste on Sunday, March 07, 2021 Rating: 5
Illumina v MGI Part 2: Has the UK lost its way on the doctrine of equivalents? Illumina v MGI Part 2: Has the UK lost its way on the doctrine of equivalents? Reviewed by Dr Rose Hughes on Saturday, February 27, 2021 Rating: 5
BREAKING: Supreme Court confirms no hard line on inventive step test in finding Cialis dosage patent obvious BREAKING: Supreme Court confirms no hard line on inventive step test in finding Cialis dosage patent obvious Reviewed by Dr Rose Hughes on Wednesday, March 27, 2019 Rating: 5
Event Report: UCL IBIL - Pregabalin: Where stand plausibility and Swiss-form claims? PART 1 Event Report: UCL IBIL - Pregabalin: Where stand plausibility and Swiss-form claims? PART 1 Reviewed by Dr Rose Hughes on Wednesday, January 09, 2019 Rating: 5
An IPSOC Q&A with Mr Justice Birss An IPSOC Q&A with Mr Justice Birss Reviewed by Rosie Burbidge on Monday, May 14, 2018 Rating: 5
Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle Top 10 issues from submissions before UK Supreme Court in Warner-Lambert v Actavis second medical use battle Reviewed by Eleonora Rosati on Thursday, February 22, 2018 Rating: 5
French Supreme Court in Finasteride second-medical use litigation acknowledges patentability of dosage regime claims French Supreme Court in Finasteride second-medical use litigation acknowledges patentability of dosage regime claims Reviewed by Annsley Merelle Ward on Thursday, January 11, 2018 Rating: 5
The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious The rise of "obvious to try" is over as Court of Appeal finds CIALIS dosage regimen patent obvious Reviewed by Annsley Merelle Ward on Sunday, November 05, 2017 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.